BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Battaglin F, Naseem M, Puccini A, Lenz HJ. Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int. 2018;18:99. [PMID: 30008616 DOI: 10.1186/s12935-018-0594-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Galetta D, Pizzutilo P, Longo V. BRMS1 expression in resected lung adenocarcinoma. Transl Lung Cancer Res 2018;7:S364-6. [PMID: 30705857 DOI: 10.21037/tlcr.2018.09.20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Adato O, Orenstein Y, Kopolovic J, Juven-Gershon T, Unger R. Quantitative Analysis of Differential Expression of HOX Genes in Multiple Cancers. Cancers (Basel) 2020;12:E1572. [PMID: 32545894 DOI: 10.3390/cancers12061572] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Stein SM, Snider J, Ali SM, Miksad RA, Alexander BM, Castellanos E, Schrock AB, Madison R, Swaminathan A, Venstrom JM, McCusker M. Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer. Future Oncol 2021;17:4101-14. [PMID: 34463133 DOI: 10.2217/fon-2021-0203] [Reference Citation Analysis]
4 Zeng C, Stroup EK, Zhang Z, Chiu BC, Zhang W. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Commun (Lond) 2019;39:12. [PMID: 30922396 DOI: 10.1186/s40880-019-0356-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
5 Woo Y, Behrendt CE, Yang A, Hahn M, Goel A, Li H, Yuan YC, Fong Y. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients. J Am Coll Surg 2021;232:483-491.e1. [PMID: 33465468 DOI: 10.1016/j.jamcollsurg.2020.12.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ieni A, Cardia R, Pizzimenti C, Zeppa P, Tuccari G. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies. J Pers Med 2020;10:E10. [PMID: 32098203 DOI: 10.3390/jpm10010010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lu Z, Luo T, Pang T, Du Z, Yin X, Cui H, Fang G, Xue X. MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis. Open Biol 2019;9:190095. [PMID: 31480991 DOI: 10.1098/rsob.190095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yang X, Zhang Q, Guan B. Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis. Onco Targets Ther 2020;13:11445-57. [PMID: 33192077 DOI: 10.2147/OTT.S279563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang J, Cai H, Dai Z, Wang G. Down-regulation of lncRNA XIST inhibits cell proliferation via regulating miR-744/RING1 axis in non-small cell lung cancer. Clinical Science 2019;133:1567-79. [DOI: 10.1042/cs20190519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
10 Mahmoudian RA, Farshchian M, Abbaszadegan MR. Genetically engineered mouse models of esophageal cancer. Exp Cell Res 2021;406:112757. [PMID: 34331909 DOI: 10.1016/j.yexcr.2021.112757] [Reference Citation Analysis]
11 Necula L, Matei L, Dragu D, Pitica I, Neagu AI, Bleotu C, Dima S, Popescu I, Diaconu CC, Chivu-Economescu M. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients. World J Gastroenterol 2020; 26(22): 3024-3033 [PMID: 32587446 DOI: 10.3748/wjg.v26.i22.3024] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lavery A, Turkington RC. Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer. Gastroenterol Rep (Oxf) 2020;8:411-24. [PMID: 33442473 DOI: 10.1093/gastro/goaa065] [Reference Citation Analysis]
13 von Döbeln GA, Wagenius G, Holtved E, Jacobsen AB, Nilsson M, Yu J, Baeksgaard L. Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction. Cancer Treat Res Commun 2020;24:100187. [PMID: 32619832 DOI: 10.1016/j.ctarc.2020.100187] [Reference Citation Analysis]
14 Chidambaram S, Markar SR. Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2021:doab046. [PMID: 34286823 DOI: 10.1093/dote/doab046] [Reference Citation Analysis]
15 Chai DM, Qin YZ, Wu SW, Ma L, Tan YY, Yong X, Wang XL, Wang ZP, Tao YS. WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells. J Exp Clin Cancer Res 2019;38:102. [PMID: 30808397 DOI: 10.1186/s13046-019-1108-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Puccini A, Battaglin F, Iaia ML, Lenz HJ, Salem ME. Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies. J Immunother Cancer 2020;8:e000404. [PMID: 32393474 DOI: 10.1136/jitc-2019-000404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
17 Ishak NS, Abdul Rahman H, Lee SHF, Lu SK, Naing L. Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer. J Gastrointest Cancer 2021. [PMID: 33392958 DOI: 10.1007/s12029-020-00559-w] [Reference Citation Analysis]
18 Xu W, Zhou G, Wang H, Liu Y, Chen B, Chen W, Lin C, Wu S, Gong A, Xu M. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer. Int J Cancer 2020;146:2901-12. [PMID: 31633800 DOI: 10.1002/ijc.32747] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
19 Zhang Z, Peng Z, Cao J, Wang J, Hao Y, Song K, Wang Y, Hu W, Zhang X. Long noncoding RNA PXN-AS1-L promotes non-small cell lung cancer progression via regulating PXN. Cancer Cell Int 2019;19:20. [PMID: 30679933 DOI: 10.1186/s12935-019-0734-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
20 Du J, Zhang G, Qiu H, Yu H, Yuan W. A novel positive feedback loop of linc02042 and c-Myc mediated by YBX1 promotes tumorigenesis and metastasis in esophageal squamous cell carcinoma. Cancer Cell Int 2020;20:75. [PMID: 32161513 DOI: 10.1186/s12935-020-1154-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 King RJ, Qiu F, Yu F, Singh PK. Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities. Front Cell Dev Biol 2021;9:667852. [PMID: 34307352 DOI: 10.3389/fcell.2021.667852] [Reference Citation Analysis]
22 Gao M, Yang W. Effects of Citrus aurantium L. on Gastrointestinal Motility and Gastric Cancer Cell Proliferation. Cancer Biother Radiopharm 2020. [PMID: 33112653 DOI: 10.1089/cbr.2020.4267] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Sharma S, George P, Waddell N. Precision diagnostics: Integration of tissue pathology and genomics in cancer. Pathology 2021:S0031-3025(21)00471-2. [PMID: 34635323 DOI: 10.1016/j.pathol.2021.08.003] [Reference Citation Analysis]
24 Gallo A, Ronzio M, Bezzecchi E, Mantovani R, Dolfini D. NF-Y subunits overexpression in gastric adenocarcinomas (STAD). Sci Rep 2021;11:23764. [PMID: 34887475 DOI: 10.1038/s41598-021-03027-y] [Reference Citation Analysis]
25 Chidambaram S, Sounderajah V, Maynard N, Markar SR. Diagnostic Performance of Artificial Intelligence-Centred Systems in the Diagnosis and Postoperative Surveillance of Upper Gastrointestinal Malignancies Using Computed Tomography Imaging: A Systematic Review and Meta-Analysis of Diagnostic Accuracy. Ann Surg Oncol 2021. [PMID: 34762214 DOI: 10.1245/s10434-021-10882-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Boldrin E, Piano MA, Alfieri R, Mazza M, Vassallo L, Scapinello A, Pilati P, Curtarello M. MSI Analysis in Solid and Liquid Biopsies of Gastroesophageal Adenocarcinoma Patients: A Molecular Approach. Int J Mol Sci 2021;22:7244. [PMID: 34298864 DOI: 10.3390/ijms22147244] [Reference Citation Analysis]
27 Zhang N, Shi J, Shi X, Chen W, Liu J. Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:12797-809. [PMID: 33363385 DOI: 10.2147/OTT.S275688] [Cited by in F6Publishing: 2] [Reference Citation Analysis]